Seminars in Arthritis and Rheumatism Seminars in Arthritis and Rheumatism RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Prevalence and incidence of psoriatic arthritis: A systematic review and meta-analysis
Psoriatic arthritis (PsA) is a specific form of inflammatory arthritis associated with psoriasis affecting in the same measure men and women but with a consistent geographic variability. Since the burden of PsA frequency has important implications in the definition of the healthcare policies, it is important to measure the frequency of disease in the general population. (Source: Seminars in Arthritis and Rheumatism)
Source: Seminars in Arthritis and Rheumatism - January 6, 2018 Category: Rheumatology Authors: Lorenza Scotti, Matteo Franchi, Antonio Marchesoni, Giovanni Corrao Source Type: research

Systematic review, and meta-analysis of steroid-sparing effect, of biologic agents in randomized, placebo-controlled phase 3 trials for Systemic Lupus Erythematosus
To systematically review, and conduct a meta-analysis of steroid-sparing effect in, phase 3 randomized, placebo-controlled trials of biologic therapies for systemic lupus erythematosus (SLE). (Source: Seminars in Arthritis and Rheumatism)
Source: Seminars in Arthritis and Rheumatism - January 6, 2018 Category: Rheumatology Authors: Shereen Oon, Molla Huq, Timothy Godfrey, Mandana Nikpour Source Type: research

Treatments for giant cell arteritis: Meta-analysis and assessment of estimates reliability using the fragility index
To better communicate the results of randomized controlled trials (RCTs) of giant cell arteritis (GCA), we propose the use of the fragility index (FI), which is an intuitive measure defined as the minimum number of subjects whose status would have to change (e.g., from having the outcome to not) to render a statistically significant result nonsignificant, or vice-versa. (Source: Seminars in Arthritis and Rheumatism)
Source: Seminars in Arthritis and Rheumatism - January 6, 2018 Category: Rheumatology Authors: Alvise Berti, Divi Cornec, Jose R. Medina Inojosa, Eric L. Matteson, M. Hassan Murad Source Type: research

Enthesitis: A Hallmark of Psoriatic Arthritis
To describe the growing importance of enthesitis in patients with psoriatic arthritis (PsA) and discuss the advantages and disadvantages of clinical and imaging methods currently used to assess enthesitis. (Source: Seminars in Arthritis and Rheumatism)
Source: Seminars in Arthritis and Rheumatism - January 6, 2018 Category: Rheumatology Authors: Gurjit S. Kaeley, Lihi Eder, Sibel Z. Aydin, Marwin Gutierrez, Catherine Bakewell Source Type: research

Abatacept in patients with rheumatoid arthritis and interstitial lung disease: A national multicenter study of 63 patients
Interstitial lung disease (ILD) is one of the most serious complications of rheumatoid arthritis (RA). In the present study, we aimed to assess the efficacy of abatacept (ABA) in patients with ILD associated to RA. (Source: Seminars in Arthritis and Rheumatism)
Source: Seminars in Arthritis and Rheumatism - January 6, 2018 Category: Rheumatology Authors: Carlos Fern ández-Díaz, Javier Loricera, Santos Castañeda, Raquel López-Mejias, Clara Ojeda-Garcia, Alejandro Olivé, Samantha Rodríguez-Muguruza, Patricia E. Carreira, Trinidad Pérez-Sandoval, Miriam Retuerto, Evelin C. Cervantes Pérez, Bryan J. F Source Type: research

Membrane attack complex (mac) deposition in lupus nephritis is associated with hypertension and poor clinical response to treatment
To study membrane attack complex in lupus nephritis as a potential biomarker for disease intensity and prognostic indicator for response to treatment. (Source: Seminars in Arthritis and Rheumatism)
Source: Seminars in Arthritis and Rheumatism - January 6, 2018 Category: Rheumatology Authors: Shudan Wang, Ming Wu, Luis Chiriboga, Briana Zeck, H. Michael Belmont Source Type: research

Compliance with Ethical Standards
Immune checkpoint inhibitors have recently received the U.S. Food and Drug Administration and European Medical Agency approval as first and second-line treatment for non-small cell lung cancer (NSCLC) [1 –3] (Source: Seminars in Arthritis and Rheumatism)
Source: Seminars in Arthritis and Rheumatism - January 6, 2018 Category: Rheumatology Authors: Marco Filetti, Elisabetta Anselmi, Serena Macrini, Francesco Rizzo, Daniela Iacono, Raffaele Giusti, Paolo Machetti Source Type: research

Pyridostigmine for the treatment of gastrointestinal symptoms in systemic sclerosis
The objective of this case series was to review our experience with pyridostigmine as a treatment for patients with SSc and symptomatic gastrointestinal disease. (Source: Seminars in Arthritis and Rheumatism)
Source: Seminars in Arthritis and Rheumatism - January 5, 2018 Category: Rheumatology Authors: Nitin K. Ahuja, Leah Mische, John O. Clarke, Fredrick M. Wigley, Zsuzsanna H. McMahan Source Type: research

Health-related quality of life in gout in primary care: Baseline findings from a cohort study
To examine gout-related, comorbid, and sociodemographic characteristics associated with generic and disease-specific health-related quality of life (HRQOL) in gout. (Source: Seminars in Arthritis and Rheumatism)
Source: Seminars in Arthritis and Rheumatism - January 5, 2018 Category: Rheumatology Authors: Priyanka Chandratre, Christian Mallen, Jane Richardson, Sara Muller, Samantha Hider, Keith Rome, Milisa Blagojevic-Bucknall, Edward Roddy Source Type: research

Extra-criteria manifestations of antiphospholipid syndrome: Risk assessment and management
In this study, we aimed to evaluate a population of patients with primary APS (PAPS) whether the extra-criteria manifestations were more frequently found in subjects with higher adjusted Global APS Score (aGAPSS) values when compared to patients with thrombotic and/or obstetric APS ( “criteria” manifestations) only. (Source: Seminars in Arthritis and Rheumatism)
Source: Seminars in Arthritis and Rheumatism - January 5, 2018 Category: Rheumatology Authors: Massimo Radin, Michelle Remi ão Ugolini-Lopes, Savino Sciascia, Danieli Andrade Source Type: research

Pyridostigmine for the treatment of gastrointestinal symptoms in systemic sclerosis
The objective of this case series was to review our experience with pyridostigmine as a treatment for patients with SSc and symptomatic gastrointestinal disease. (Source: Seminars in Arthritis and Rheumatism)
Source: Seminars in Arthritis and Rheumatism - January 5, 2018 Category: Rheumatology Authors: Nitin K. Ahuja, Leah Mische, John O. Clarke, Fredrick M. Wigley, Zsuzsanna H. McMahan Source Type: research

Health-related quality of life in gout in primary care: Baseline findings from a cohort study
To examine gout-related, comorbid and sociodemographic characteristics associated with generic and disease-specific Health-Related Quality Of Life (HRQOL) in gout. (Source: Seminars in Arthritis and Rheumatism)
Source: Seminars in Arthritis and Rheumatism - January 5, 2018 Category: Rheumatology Authors: Priyanka Chandratre, Christian Mallen, Jane Richardson, Sara Muller, Samantha Hider, Keith Rome, Milisa Blagojevic-Bucknall, Edward Roddy Source Type: research

Extra-criteria manifestations of antiphospholipid syndrome: Risk assessment and management
In this study, we aimed to evaluate a population of patients with primary APS(PAPS) whether the extra-criteria manifestations were more frequently found in subjects with higher adjusted Global APS Score (aGAPSS) values when compared to patients with thrombotic and/or obstetric APS( “criteria” manifestations) only. (Source: Seminars in Arthritis and Rheumatism)
Source: Seminars in Arthritis and Rheumatism - January 5, 2018 Category: Rheumatology Authors: Massimo Radin, Michelle Remi ão Ugolini-Lopes, Savino Sciascia, Danieli Andrade Source Type: research

Editorial Board
(Source: Seminars in Arthritis and Rheumatism)
Source: Seminars in Arthritis and Rheumatism - December 23, 2017 Category: Rheumatology Source Type: research